Global longitudinal strain is superior to ejection fraction for detecting myocardial dysfunction in end-stage renal disease with hyperparathyroidism

Table 2 Biochemical and left ventricular remodeling variables in the study groups: Control, end-stage renal disease on hemodialysis and end-stage renal disease on peritoneal dialysis

Variables	Control	ESRD-HD	ESRD-PD	P value
Biochemical
PTH (pg/mL)	50 ± 4.55a,c	1188 ± 203.9	1188 ± 203.9	< 0.0001
Ca2+ (mg/dL)	8.55 ± 2.34	8.47 ± 0.14	8.38 ± 0.09	NS
P (mg/dL)	4.56 ± 2.28	4.75 ± 0.24	4.75 ± 0.28	NS
Ca2+/P (mg2/dL2)	45.32 ± 1.05	42.31 ± 2.35	39.87 ± 2.5	NS
Albumin (mg/dL)	4.47 ± 0.10a,c	4.13 ± 0.12	3.94 ± 0.06	< 0.0284
Hemoglobin (g/dL)	15.3 ± 0.12a,c	8.73 ± 0.24	8.91 ± 0.22	< 0.0001
LV remodeling
LV mass (g)	133.8 ± 3a,c	182.7 ± 12.2	186.6 ± 15	< 0.0001
LVMI (g/m2)	70.65 ± 2.11a,c	130.2 ± 6.24	127.5 ± 6.55	< 0.0001
RWT	0.39 ± 0.016a,c	0.51 ± 0.01	0.51 ± 0.02	< 0.0001

^aP < 0.05, control vs ESRD-HD.

^cP < 0.05, control vs ESRD-PD.

The data represent the mean SD. ANOVA followed by a Tukey test was performed and was considered significant. ESRD: End-stage renal disease; ESRD-HD: ESRD on hemodialysis; ESRD-PD: ESRD on peritoneal dialysis; PTH: Plasma parathyroid hormone; LV: Left ventricular; LVMI: LV mass index; NS: Not significant.